CDMO Catalent

CDMO Catalent

featured image of Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
Companies

Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market

BIOT

📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.

featured image of Novo Holdings Acquires Catalent for $165bn: Expanding Presence in Pharma Manufacturing
Companies

Novo Holdings Acquires Catalent for $165bn: Expanding Presence in Pharma Manufacturing

BIOT

📢 Novo Holdings acquires CDMO Catalent for $16.5bn, expanding their presence in pharmaceutical manufacturing and development. 💼💉🌍

Previous 123

Bioprocessupdates

©2023 - 2025 BioprocessUpdates

PRIVACY POLICY terms of service contact